Resultados de la búsqueda 81-90 of 6929 for immunosuppressant drugs
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
Focus includes practical updates on subspecialty topics, including anesthesiology, allergy, cardiovascular diseases, consultative medicine, dermatology, ...
Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...
The purpose of this study is to evaluate the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioblastoma that has come back ...
The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all have ...
A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...
- Investigational Drug Sub-study A: Brigatinib. A Study to Develop Liquid Biopsy for Pediatric Brain Tumor Patients. Rochester, Minn. The purpose of this study ...
... immunosuppressants. Exploratory Goals. To evaluate changes in gut ... drugs. Numeración de páginas Estudios clínicos. AnteriorPágina anterior · Ir a ...
albicans exposure during early life on the systemic immune populations. Mayo Clinic Drug Allergy Repository. Jacksonville, Fla., Scottsdale/Phoenix, Ariz., Eau ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.